Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2026 Nov 8;224(11):e70330. doi: 10.5694/mja2.70330

Opportunities and Challenges to Achieving the Australian Cancer Plan Goal of World Class Health Systems for Optimal Cancer Care

Carolyn Ee 1,✉, Ria Joseph 1, Elise Button 1, Stacey George 2, Makala Castelli 3, David Currow 4, Prue Cormie 1,5,6, Olivia Farrer 7, Michael Jefford 6,8,9, Nicolas H Hart 1,10, Chad Y Han 1, Deidre D Morgan 7, Michael P Osborn 11, Candice Oster 12, Joel Rhee 13, Anna Ugalde 14, Eric Yeung 15, Catherine Paterson 1
PMCID: PMC13744784  PMID: 43000003

ABSTRACT

The Australian Cancer Plan is a 10‐year national framework to improve cancer outcomes for all Australians. Its third Strategic Objective envisions integrated, coordinated, data‐driven high‐quality health systems that deliver optimal cancer care and outcomes, with survivorship and palliative care as priority areas for action. In this perspective article, we examine the challenges and opportunities to achieving this objective. We identify persistent gaps in survivorship and palliative care and in equity for priority populations. To achieve the stated objective, we present opportunities to expand team‐based models of follow‐up care, strengthening of comprehensive cancer networks and embedding patient‐reported outcome and experience measures nationally.

Keywords: administration and organisation, cancer, health policy

1. Introduction

More Australians today live longer with and beyond cancer than ever before [1]. However, this accentuates an ongoing challenge: our health system must provide optimal care for ever‐growing numbers of people surviving cancer [2].

This perspective article is part of a series examining progress in implementing each Strategic Objective of the Australian Cancer Plan (ACP) [3]. Launched in 2023, the ACP is a 10‐year national framework designed to improve cancer outcomes and experiences for all Australians affected by cancer. The ACP is structured around six Strategic Objectives that identify where national focus and effort are required. This article focuses on Strategic Objective 3, ‘World Class Health Systems for Optimal Care’. It examines the challenges and evidence‐based opportunities within the ACP's priority areas for action for this objective (Box 1), which are survivorship [4] and palliative care [5] (Box 2); multidisciplinary and person‐centred models of care; and networked cancer care. These areas represent persistent challenges within Australian cancer care despite strong evidence supporting reform. As such, this article focuses on the care and outcomes beyond the period of active cancer treatment.

BOX 1. Australian Cancer Plan Strategic Objective 3 Priority Areas for Action.

Priority areas Action
10‐year ambition
  • Integrated, coordinated, data‐driven, high‐quality health service systems that consistently deliver optimal cancer care and excellence in outcomes

Priority areas for action
Survivorship
  • Improving the integration and coordination of care between health and other service providers to:

    • Enable seamless, holistic, patient‐centred care beyond the period of active cancer treatment;

    • Increase support of survivorship‐focused research with an emphasis on cancer follow‐up.

Palliative care
  • Improving equity of early access and culturally appropriate specialist expertise for people with cancer requiring palliative care and strengthening knowledge and awareness of patients and their families on what to expect during end‐of‐life care.

  • Voluntary assisted dying, where relevant, should also be considered.

Multidisciplinary care
  • Improving processes, systems and infrastructure, empowering a fully engaged healthcare team who can work to the top of their scope of practice and optimising membership of multidisciplinary care teams to ensure the right people are involved throughout the patient journey.

Comprehensive cancer care
  • Development of a shared understanding of what this includes, its benefits and how it is demonstrated and evaluated.

Person‐centred models of care
  • Maximising quality, safety and accessibility of value‐based models of shared care, developing new models for integrated care across the sector, promoting personalised care and optimising systems to provide care that is personalised, safe and high quality.

BOX 2. Definitions used throughout this article and within the Australian Cancer Plan.

Term Definition
Survivorship
  • Survivorship provides a focus on the health and well‐being of people affected by cancer, which includes the person living with and beyond cancer, as well as their family members and caregivers [4].

Palliative care
  • Palliative care is defined as an approach that improves the quality of life of patients—and their families—facing problems associated with life‐threatening illness. It prevents and relieves suffering through early identification, assessment and treatment of pain and other physical, psychosocial and spiritual issues [5].

  • In this article, we refer to palliative care for people with cancer.

2. The Challenge of Achieving World Class Health Systems for Optimal Cancer Care

The ACP's 10‐year ambition for this strategic objective is for integrated, coordinated, data‐driven, high‐quality health systems that consistently deliver optimal cancer care and excellence in outcomes. Central to achieving this ambition are efforts to improving service integration and coordination, using patient experience and outcomes data to identify and address gaps in service delivery and improving equitable access to evidence‐based models of integrated multidisciplinary care across the continuum.

2.1. Current Status of the Australian Health System

There is no single agreed definition of a world class health system. The Lancet Global Health Commission on High Quality Health Systems characterises high‐quality systems as those that consistently optimise health in a given context, are valued and trusted by the people who use them, are available and affordable for all people, adapt as population needs change and avoid waste [6]. Broadly, when compared with other Organisation for Economic Co‐operation and Development (OECD) countries, Australia's health system performs well, ranking first for the health system performance domains of equity and health outcomes, second for administrative efficiency and fifth for care process in 2024 (Box 3) [7]. However, there are considerable health system strains in Australia [1]. Our population is ageing, with higher disease burden and complexity [1], heightening significant pressures on clinical services [8]. Within this context, cancer contributes to the highest burden of disease and the second greatest health system expenditure [1]. Moreover, the number of Australians living with and beyond cancer is growing, now estimated at over 1.6 million people [9]. A significant challenge for Australia's health system is how to support the long‐term needs of this growing population [2].

BOX 3. Definitions used within health system performance domains.

Term Definition
Equity How people with below‐average or above‐average incomes differ in access to health care and care experience.
Health outcomes The outcomes most likely to be responsive to healthcare interventions.
Administrative efficiency Measures of the challenges doctors have in dealing with insurance or medical claims issues, requirements for providers to report clinical or quality data to government agencies and patient time resolving bill disputes and paperwork.
Care process Whether care that is delivered includes features and attributes that most experts around the world consider to be essential to high‐quality care.

2.2. Health System Challenges in Survivorship and Palliative Care

The ACP envisions seamless, holistic, patient‐centred care beyond the period of active cancer treatment. However, implementation of this remains limited in Australia [10]. A fundamental problem is the dispersed nature of services, reflected in a lack of clear system ownership and corresponding funding. Follow‐up cancer care in Australia is currently predominantly provided through oncology services, focuses on disease recurrence and is largely unable to address other survivorship needs, such as chronic disease management and psychosocial support. For instance, Victorian data on follow‐up for colorectal cancer survivors at a comprehensive cancer centre demonstrates limited focus on management of long‐term complications, psychosocial issues, health promotion or screening for other cancers [11]. This is a significant gap because evidence suggests health‐related quality of life is lower for two‐thirds of people living with and beyond cancer, compared with people without cancer, with common challenges including psychosocial issues as well as fatigue, pain, sleep disturbance, weight changes, neuropathy and cognitive impairment [12].

Delivery of comprehensive cancer care and person‐centred models of care integrated across the health system are also priorities within this strategic objective. However, although significant areas of the health system such as primary care strive to provide person‐centred care for individuals with chronic disease (including cancer) [13], challenges such as Australia's federated system create fragmented service delivery, poor communication, lack of role clarity and variable care pathways across jurisdictions and limit primary care's potential role in survivorship [11, 14]. A practical example of these challenges is Australia's lack of a functional single digital patient record that integrates primary and tertiary care electronic medical records, despite ongoing major investments in interoperability [15]. This must be addressed if the ACP's ambition of seamless care after active cancer treatment is to be realised.

Underpinning Australia's health system challenges is the continuing global de‐prioritisation of primary care by governments and other funding bodies, despite robust evidence that primary care is the most efficient and cost‐effective way to optimise population health outcomes [16]. Recent policy initiatives such as the Bulk Billing Practice Incentive Program aim to increase the proportion of Australians accessing bulk‐billed general practitioner consultations. However, this incentivises high‐volume care, and the lack of corresponding increases in Medicare rebates for longer consultations disincentivises provision of comprehensive care.

Another priority for this strategic objective is optimising delivery of multidisciplinary team‐based care. Yet, funding reform to enable this has not occurred. For example, despite evidence for survival and other benefits, exercise medicine is still not embedded as standard of care [17, 18] and Australian evidence demonstrates persistent barriers to accessing psychosocial and mental health support in cancer care [19]. A specific gap is the absence of expansion of the allied health cap with a Chronic Condition Management Plan, unchanged since its introduction as a Team Care Arrangement in 2004 [20]. This restricts equitable access to occupational therapy, physiotherapy and speech pathology services, vital for people with cancer.

Palliative care for people with cancer has made great strides in physical symptom management and psychosocial care, but focused management on better optimising physical independence for as long as possible receives too little emphasis [21, 22]. Consequently, a key patient‐defined outcome is ignored with substantial flow‐on effects to the family and friends who provide care. The Palliative Care Outcomes Collaboration (PCOC)—a Commonwealth‐funded quality improvement program—established national benchmarks for symptom management and psychospiritual care but not function [23]. Access to rehabilitative supports is not integrated into specialist palliative care settings, and services have systematically under‐invested in an allied health workforce in palliative care in Australia. Despite their pivotal role in delivering patient‐centred outcomes in palliative care, allied health care is not reported as part of the palliative care workforce by the Australian Institute of Health and Welfare. General practice palliative care reporting is similarly limited [24]. Compounding this, schemes such as My Aged Care, the National Disability Insurance Scheme and the End‐of‐Life Pathway are not tailored to meet individual care needs of people with advanced cancer at end of life.

2.3. Equity of Access and Outcomes for Priority Populations

There is an urgent need to ensure cancer outcomes are equitable for all Australians. The ACP outlines eight priority populations needing additional and targeted focus and support to reduce disparities in cancer outcomes due to cultural, social, commercial and environmental determinants of health, including characteristics historically linked to discrimination or exclusion, that impact on access to care (Box 4). Barriers to accessing optimal care across the cancer continuum are compounded with cancer‐related inequities across priority populations; however, these should not be considered uniform. These inequities reflect the influence of structural, social and health system factors rather than characteristics of individuals or communities themselves [25].

BOX 4. Priority population groups of the Australian Cancer Plan.

  • Aboriginal and Torres Strait Islander people

  • People living in rural and remote areas

  • Lesbian, gay, bisexual, transgender, intersex, queer and asexual (LGBQTIA+) people

  • People from culturally and linguistically diverse (CALD) backgrounds

  • People living with disability

  • People in lower socio‐economic groups

  • People living with a mental illness

  • Older Australians

  • Adolescents and young adults

  • Children

For example, Aboriginal and Torres Strait Islander peoples, people living in rural and remote areas, people experiencing socio‐economic disadvantage and some culturally and linguistically diverse communities experience poorer screening participation [26, 27, 28], later diagnosis [27] and worse cancer outcomes than the broader population [29, 30]. People with intellectual disability face additional barriers to timely and appropriate cancer care, particularly around legal capacity such as involvement in decision‐making and poor symptom awareness [31]. Australians living in rural and remote areas face poorer access to specialist oncology workforce, limited clinical trial and supportive care access and prohibitive cost of travel [28, 32].

3. Opportunities

In this section, we outline cost‐effective, efficient and evidence‐based opportunities within the priority areas for action for this strategic objective. We suggest investment and research priorities (Tables 1 and 2) to progress action toward the 10‐year ambition of world class health systems for optimal cancer care, with a focus on survivorship and palliative care.

TABLE 1.

Priority investments to strengthen survivorship, palliative care and multidisciplinary cancer care in Australia.

Context and rationale Investment priority and alignment with ACP objective Stakeholder perspectives Forward looking statement
Current follow‐up care fails to address health promotion and psychosocial needs, costs the health system more and is not preferred by patients or providers.
  • Sustained funding for national implementation of shared care, nurse‐led, nurse‐enabled and primary care‐led models as standard care.

  • Funded roles for nurses and care coordinators.

  • Rebates for longer consultations.

  • Trial and evaluation of patient‐initiated follow‐up.

  • ACP: 3.2.3, 3.2.4, 3.5.3.

Patients and providers prefer shared care over cancer service‐led models; this approach creates opportunities for care closer to home and addresses broader survivorship domains. Every person with cancer can choose the follow‐up model that suits them; providers are funded and supported to deliver team‐based models as standard care.
Primary care is the most cost‐effective way to address disparities in cancer outcomes for priority population groups but is chronically underfunded.
  • Increase Medicare rebates for longer general practitioner consultations.

  • Expand WIP and MyMedicare a with equity weighting for priority populations.

  • Increase the CCMP allied health cap.

  • ACP: 3.2.3, 3.5.1, 3.5.3.

Patients and providers value primary and multidisciplinary care, but rising costs are causing foregone care and provider attrition, with few adjustments for social determinants of health. All Australians access the benefits of primary care according to their need across the cancer continuum, with primary care incentivised to provide comprehensive, coordinated care addressing the needs of priority populations close to home.
Allied health is underfunded and not counted in national benchmarks.
  • Expand the WIP and National PHN Allied Health Framework.

  • Increase the CCMP allied health cap.

  • Embed functional outcomes in PCOC benchmarks.

  • Fund palliative rehabilitation in community settings.

  • ACP: 3.2.3, 3.2.4, 3.5.3.

Patients want timely, affordable access to allied health and rehabilitation. Clinicians want clear referral pathways, top‐of‐scope roles and recognition of allied health in palliative care workforce data. All Australians access the benefits of allied health across the cancer continuum.
Quality of care focuses on survival and process measures, failing to capture the lived experience and functional outcomes of survivors.
  • National standardisation and routine PROMs/PREMs collection within the National Cancer Data Framework.

  • Fund a national cancer patient experience survey.

  • Establish HRQoL and cultural safety as primary quality indicators alongside survival.

  • ACP: 3.2.1, 3.5.1.

Patients want quality of life and experience to count. Australia is a world leader in person‐centred cancer quality measurement, enabling systematic identification of disparities and driving accountability across the full continuum.
The ACCN lacks formal accreditation, consistent governance and assured federal funding, limiting its capacity to drive equitable national change.
  • Formal governance and accreditation framework for the ACCN.

  • Sustained federal investment in network infrastructure and shared data/analytics capacity.

  • OCPs mandated across all nodes.

  • Expanded clinical trials access.

  • ACP: 3.2.2, 3.5.1, 3.5.2.

Clinicians in smaller centres want structured collaboration and shared expertise with CCCs. Australia is an international exemplar of equitable, decentralised cancer care.
Australia lacks a functional SDPR integrating primary and tertiary care EMRs despite major investments in interoperability.
  • Accelerated national investment in a functional SDPR linking primary, tertiary and community records.

  • Mandate interoperability standards across jurisdictions.

  • Digital infrastructure to embed PROMs/PREMs in routine clinical workflows.

  • ACP: 3.2.3, 3.5.1.

Patients want their records to follow them across care settings. General practitioners cite poor information transfer from tertiary care as the most common barrier to optimal cancer care in primary care. Care is coordinated, seamless and integrated.

Abbreviations: ACCN, Australian Comprehensive Cancer Network; ACP, Australian Cancer Plan; CCC, Comprehensive Cancer Centre; CCMP, Chronic Condition Management Plan; EMR, electronic medical record; HRQoL, health‐related quality of life; OCP, Optimal Care Pathway; PCOC, Palliative Care Outcomes Collaboration; PHN, Primary Health Network; PREMs, patient‐reported experience measures; PROMs, patient‐reported outcome measures; SDPR, single digital patient record; WIP, Workforce Incentive Program.

a

MyMedicare is the Australian voluntary patient enrolment scheme.

TABLE 2.

Research priorities to strengthen survivorship, palliative care and multidisciplinary cancer care in Australia.

Context and rationale Research priority and alignment with ACP objective Stakeholder perspectives Forward looking statement
Models of care
  • Implementation of multidisciplinary follow‐up models is inconsistent across cancer types, settings and jurisdictions.

  • Australian evidence base for patient‐initiated follow‐up is absent.

  • Pragmatic implementation trials comparing effectiveness and cost‐effectiveness of shared care, nurse‐led, patient‐initiated follow‐up and cancer navigation models across multiple cancer types in Australian primary care/community settings.

  • Explore hybrid models, digital tools in patient‐initiated follow‐up.

  • ACP: 3.2.3, 3.5.3.

  • Patients and oncologists support shared care models.

  • General practitioners and primary care nurses need role clarity, communication infrastructure and adequate remuneration.

  • Within 10 years, every person completing active cancer treatment has access to a risk‐stratified follow‐up model matched to their needs, close to home.

Primary care
  • Primary care is a cost‐effective way to deliver improved population health outcomes, especially for priority populations, but research on how to deliver survivorship care in primary care in Australia is limited.

  • Co‐designed implementation research on scalable primary care‐led survivorship models.

  • Modelling and evaluation of flexible, blended funding models on quality of survivorship care in general practice.

  • Longitudinal studies on the impact of relational continuity of care in primary care on survivorship and palliative care outcomes, especially for priority populations.

  • ACP: 3.2.3, 3.5.1, 3.5.3.

  • People with cancer want accessible, affordable and high‐quality survivorship care close to home and with a trusted provider.

  • General practitioners and practice nurses need evidence‐based tools and funded care coordination time.

  • Within 10 years, cancer is managed as a chronic disease in primary care.

Rural and remote survivorship models
  • Australians living in rural and remote areas face significant barriers to optimal cancer care access and outcomes.

  • Co‐design and tailor survivorship models in partnership with rural and remote communities, taking a place‐based approach.

  • Rural and remote communities want to contribute their strengths and local expertise to develop solutions to improve survivorship care.

  • Within 10 years, geographical disparities in access to care and outcomes are minimised.

Allied health as standard of care
  • Allied health is yet to be embedded as standard of care for people with cancer and is not counted in PCOC benchmarks and AIHW palliative care workforce data.

  • Implementation studies of structured, interprofessional allied health models and pathways measuring clinical outcomes and cost‐effectiveness.

  • Health economic modelling of CCMP cap expansion.

  • Allied health data included in cancer and palliative care benchmarks and workforce data.

  • ACP: 3.2.3, 3.2.4, 3.5.3.

  • Patients face prohibitive out‐of‐pocket costs for allied health.

  • Referrals are still ad hoc.

  • Within 10 years, psychosocial care, exercise, nutrition, occupational therapy, rehabilitation and other allied health services are embedded as standard, funded components of survivorship and palliative care.

Patient‐reported outcomes and experience measures
  • There is no national standardised PROMs or PREMs system in cancer care.

  • National PROMs/PREMs framework with culturally adapted measures for priority populations embedded into the National Cancer Data Framework.

  • ACP: 3.2.1, 3.5.1.

  • Patients want quality of life and experience to be counted.

  • Clinicians need validated, actionable tools.

  • Policymakers need disaggregated longitudinal data to identify and address equity gaps.

  • Within 10 years, nationally standardised PROMs/PREMs are routinely collected for all Australians with cancer, integrated into the National Cancer Data Framework.

Comprehensive care networks
  • The ACCN lacks formal accreditation, consistent governance and robust evaluation.

  • No national dataset allows benchmarking across network nodes or measurement of equity impacts by geography.

  • National ACCN evaluation study comparing outcomes and cost‐effectiveness across network nodes.

  • International comparative studies on accreditation models.

  • Shared data infrastructure.

  • ACP: 3.2.2, 3.5.1, 3.5.2.

  • Health service providers and policy makers need data on gaps in service delivery in order to provide equitable care.

  • Policymakers require evidence on the impact of networked cancer care.

  • Within 10 years, every Australian with cancer receives best practice care regardless of location, with the ACCN reducing geographical disparities.

Abbreviations: ACCN, Australian Comprehensive Cancer Network; ACP, Australian Cancer Plan; AIHW, Australian Institute of Health and Welfare; CCMP, Chronic Condition Management Plan; PCOC, Palliative Care Outcomes Collaboration; PREMs, patient‐reported experience measures; PROMs, patient‐reported outcome measures.

3.1. Comprehensive Cancer Networks

Comprehensive cancer networks offer a platform to deliver on the 10‐year ambition of integrated, coordinated data‐driven high‐quality health systems for optimal cancer care and outcomes. Comprehensive cancer centres (CCCs) are regarded as the highest tier of cancer centres, demonstrating excellence in clinical care, research and education using a multiprofessional, interdisciplinary model. Historically, these are few in Australia—though more are currently under development. Thus, access to CCCs in Australia is limited and inequitable [33]. Comprehensive cancer networks formally link larger metropolitan with smaller cancer centres and primary care, allowing decentralised delivery of comprehensive cancer care where clinically appropriate [34] and facilitating collaboration, shared data and data analytics, clinical trials capacity and promotion of comprehensive care principles, while supporting care close to home. Although CCCs will continue to play a pivotal role as network hubs, several states are pursuing decentralised models (e.g., the South Australian Comprehensive Cancer Network). Networked links must have a clearly defined purpose, be responsive to local contexts and avoid unnecessary barriers to deliver demonstrable benefits [34].

Australia's Comprehensive Cancer Network (ACCN) was established to virtually connect cancer services, multidisciplinary teams, primary care and CCCs nationwide [35], facilitating collaboration and sharing of expertise [35]. World class survivorship and palliative care, equitable access and new models of care can be delivered through an effectively functioning ACCN. Formal accreditation, consistent governance structures, nationally consistent outcome data, rigorous evaluation and sustainability of future government funding must be prioritised in order to achieve the ACCN vision of world class comprehensive care. Australia has a timely opportunity to generate evidence on how comprehensive cancer networks can provide equitable and world class cancer care through an informal hub and spoke approach, given the right funding and infrastructure.

3.2. New Models of Care

Our health system must shift urgently from cancer service‐led care towards implementing tailored multidisciplinary models for cancer survivors (see Box 5 for definitions [36, 37, 38]). Working with oncology services, the skills of primary care, nursing, allied health and community‐based providers need to be leveraged. This approach aligns with key strengths of the Australian health system, where primary care delivers most ongoing chronic disease management. It ensures the provision of more comprehensive, person‐centred care throughout for cancer survivors closer to homes and aligns with the 10‐year ambition for this strategic objective to build integrated, coordinated health systems.

BOX 5. Models of follow‐up cancer care.

Follow‐up care models Description
Oncology‐led models Medically focused care delivered in the hospital or specialist cancer care setting, typically with a heavy focus on detection of recurrence or new cancers [36].
Shared care models A structured collaboration between the non‐general practitioner specialist/hospital‐based oncology team and a primary care provider, capitalising on the complementary expertise of various healthcare providers [36].
Primary care‐led models A model of care where follow‐up care is predominantly provided in the primary care setting and led by a general practice team [36].
Nurse‐led models A model of care where nurses take the primary leadership role in providing and coordinating follow‐up care to manage the needs of people affected by cancer [37].
Nurse‐enabled models A model of care where nurses take an essential role in enabling or removing barriers to supported self‐management or care provision arrangements by members of the multidisciplinary team (oncologist, haematologist, surgeon, general practitioner, allied health, other nurses or in combination) in caring for people affected by cancer [37].
Patient‐initiated follow‐up A person‐centred approach that puts ‘people with cancer in the driver's seat’ to promote engagement and empower patients to initiate their hospital follow‐up on an as required basis [38].

Australian studies demonstrate that shared care, nurse‐led and nurse‐enabled models for cancer survivors result in similar disease and patient outcomes, reduce fragmentation, are preferred by patients, result in greater provision of health promotion and disease prevention and are better value for the health system [36, 39, 40, 41]. People living with and beyond cancer, their general practitioners and their oncologists are supportive of shared care [36]. Widespread implementation of these models as standard care must be an immediate health system priority and must be supported by evidence from pragmatic implementation trials and consistent policies at a Commonwealth and jurisdictional level. Political resolve must be harnessed to redirect funding for care coordination and to invest in medical record interoperability that is inclusive of primary care. Processes for regular and accurate data collection for ongoing evaluation of effectiveness and cost‐effectiveness of these models of care should be implemented [42].

In order to close the gap in cancer outcomes, delivery of cancer control must recognise the critical importance of primary care teams including nurses and allied health practitioners. As first point of contact, primary care practitioners provide a key range of services for cancer survivors [13, 43]. Relational continuity of care in primary care builds trust and is associated with higher cancer prevention and screening behaviours in rural [44] and culturally and linguistically diverse (CALD) populations [45], improved patient experience, greater adherence to recommended treatment plans [46] and improved access to palliative care in CALD populations [47]. Fully leveraging the skills of primary care teams in cancer care is one of the most efficient and cost‐effective ways to reduce disparities in cancer outcomes, and research funding for how to deliver this should be prioritised. Governance and financing of primary care must be commensurate with its significant role in survivorship and population health [48].

There are immediate opportunities to co‐design and tailor survivorship care models with rural and remote communities that reflect local workforce capacity, service availability and community priorities [28]. Evidence suggests that sustainable improvements in rural cancer care require place‐based approaches developed in partnership with communities and responsive to local contexts [49]. Leveraging existing primary care relationships, local knowledge and community assets may improve the acceptability, accessibility and sustainability of survivorship care interventions [49]. Policy reforms should support flexible models that enable local adaptation while maintaining equitable standards of care across jurisdictions [28].

Our health system must move beyond ad hoc allied health referral to structured, systemic approaches embedding affordable access to allied health practitioners as standard of care. For example, dietitian‐led interventions for people with cancer minimise weight loss, enhance quality of life and improve overall diet quality [50, 51]. Exercise is a well‐established guideline‐recommended adjunct therapy in cancer care [18, 52] and people with cancer want to be referred to exercise medicine [52, 53]. Models utilising team members such as allied health assistants, aged care workers, skilled carers and lay or peer navigators improve clinical outcomes and therapy access [54], allowing clinicians to focus on top‐of‐scope tasks. Optimisation of this workforce in supporting care alongside clinicians in oncology should be a priority and should be supported by evidence from implementation studies of structured models and pathways.

Recent investments in multidisciplinary teams in primary care include the National Primary Health Network Allied Health in Primary Care Engagement Framework and the Workforce Incentive Program (WIP). WIP funding has predominantly been used by practices to bolster much‐needed nursing hours. This funding must be expanded and sustained to adequately support access to allied health. Other reforms such as voluntary patient registration (MyMedicare) should focus on further flexible, blended funding models to incentivise multidisciplinary care and care coordination. An increase in the allied health cap for chronic conditions management is urgently needed as is evaluation of the role of cancer navigators to improve integrated care for cancer survivors. Recent rural loading for the WIP has been welcomed, but tailoring for other priority populations must be implemented.

Clinician‐led follow‐up for cancer is associated with high resource usage and cost [55], patient burden and increase in fear of cancer recurrence [56], with limited evidence for survival benefits from more intensive follow‐up [57]. Patient‐initiated follow‐up, coupled with remote monitoring, offers flexibility and reduced burden of hospital visits [38], while ensuring people living with and beyond cancer still receive recommended surveillance. However, suitability depends on individual needs, preferences, health literacy and capacity for self‐management. Healthcare professionals, particularly nurses, are well positioned to lead these efforts in Australia. Future research should explore hybrid models, digital tools and broader international perspectives to optimise delivery of patient‐initiated follow‐up.

The World Health Organization recommends palliative rehabilitation across all settings irrespective of prognosis [58]. Incorporation of allied health into palliative care optimises function, including physical independence for as long as possible [59], and, across the population, may reduce acute care admissions [60, 61]. Queensland Health's Palliative Care Equipment Program (Medical Aids Subsidy Scheme) provides an exemplar of timely care provision through a unified system. Targeted allied health‐led prescription of assistive equipment, with ability to bypass restrictions of the National Disability Insurance Scheme and My Aged Care, shows health economic benefits including reduced length of stay [62]. It highlights the importance of flexible systems enabling tailored care.

3.3. Patient‐Reported Measures

Measurement of quality outcomes and experiences are fundamental to a world class health system, with emphasis on national data that measures equity, person‐centred care and continuous monitoring across the cancer continuum. Although process‐based indicators are useful to drive process‐related improvements, they do not capture patients' experiences [63]. Alongside survival, core domains of patient experience, health‐related quality of life and cultural safety should be key measures of care quality [64]. Internationally, patient‐reported outcome and experience measures (PROMs, PREMs) are recognised as critical quality indicators guiding both clinical care and system‐level performance [65]. National standardisation and harmonisation of PROMs and PREMs, similar to the PCOC [66], the United Kingdom National Cancer Patient Experience Survey [67] and the Cancer Quality of Life Survey [68], are urgently needed to truly measure world class health systems and to realise the 10‐year ambition of data‐driven high‐quality health systems and achieving optimal cancer outcomes. This should focus on measuring and addressing disparities in experience and outcomes for priority populations and should be embedded into the National Cancer Data Framework in order to systematically capture unmet needs and drive reform.

4. Conclusion

The ACP is an ambitious plan, but necessarily so. Achieving a world class health system that delivers optimal outcomes for Australians diagnosed with cancer requires a deliberate evolution in how care is organised, funded and delivered. We outline timely, cost‐effective and efficient health system strategies to optimise care and outcomes for the growing numbers of Australians living with and beyond cancer. These reforms represent practical opportunities to advance the ACP's vision of world class, person‐centred care for all Australians.

Unlike countries with legislated cancer control frameworks, Australia adopts a non‐statutory cancer plan approach [69]. Strengthened legislative frameworks, together with stronger accountability and system‐wide collaboration, are needed in order to ensure reforms that deliver truly world class cancer care and outcomes.

Author Contributions

Carolyn Ee: conceptualisation, methodology, project administration, writing – original draft, writing – review and editing. Ria Joseph: conceptualisation, methodology, writing – original draft, writing – review and editing. Elise Button: conceptualisation, methodology, writing – original draft, writing – review and editing. Stacey George: conceptualisation, methodology, writing – original draft, writing – review and editing. Makala Castelli: conceptualisation, methodology, writing – original draft, writing – review and editing. David Currow: conceptualisation, methodology, writing – original draft, writing – review and editing. Prue Cormie: conceptualisation, methodology, writing – original draft, writing – review and editing. Olivia Farrer: conceptualisation, methodology, writing – original draft, writing – review and editing. Michael Jefford: conceptualisation, methodology, writing – original draft, writing – review and editing. Nicolas H. Hart: conceptualisation, methodology, writing – original draft, writing – review and editing. Chad Han: conceptualisation, methodology, writing – original draft, writing – review and editing. Deidre D. Morgan: conceptualisation, methodology, writing – original draft, writing – review and editing. Michael P. Osborn: conceptualisation, methodology, writing – original draft, writing – review and editing. Candice Oster: conceptualisation, methodology, writing – original draft, writing – review and editing. Joel Rhee: conceptualisation, methodology, writing – original draft, writing – review and editing. Anna Ugalde: conceptualisation, methodology, writing – original draft, writing – review and editing. Eric Yeung: conceptualisation, methodology, writing – original draft, writing – review and editing. Catherine Paterson: conceptualisation, methodology, writing – original draft, writing – review and editing.

Funding

This study was supported by Flinders University.

Disclosure

Not commissioned; externally peer reviewed.

Conflicts of Interest

Carolyn Ee is Director of the Primary Care Collaborative Cancer Clinical Trials group, which is funded by the Cancer Australia Support for Cancer Clinical Trials program; is an Expert Working Group Member for the Review and Update of the Optimal Care Pathway (OCP) Templates; and an Expert Cancer Control panel member (survivorship), Cancer Australia. She has received grant funding from Cancer Australia through the Supporting People with Cancer scheme. She is a member of the South Australian Comprehensive Cancer Network (SACCaN) Steering Committee. David Currow was the founding Chief Executive Officer (CEO) of Cancer Australia; and was NSW Chief Cancer Officer and CEO of the Cancer Institute NSW. Michael P. Osborn is Chief Cancer Officer of SACCaN. Michael Jefford chaired the Cancer Wellness Working Group for Cancer Australia in 2012–2014 and has received grant funding from Cancer Australia through various schemes. Olivia Farrer is Senior Research Fellow for CareSearch, including palliAGED, a National Palliative Care Project funded by the Department of Health, Disability and Ageing. Stacey George holds the position of Professor of Primary Care and Integration which is jointly funded with the Adelaide Primary Health Network. Nicolas Hart is a member of Cancer Australia's Expert Panel for Supportive Care in Cancer, Chair of the Expert Working Group and Steering Committee member overseeing the development of the Optimal Care Pathway for LGBTQIA+ People with Cancer; is Chair of the Clinical Oncology Society of Australia's Survivorship Executive; and a Scientific Committee member of the Primary Care Collaborative Cancer Clinical Trials group, which is funded by the Cancer Australia Support for Cancer Clinical Trials program. Anna Ugalde is the lead of the ECORRA Research Program and receives funding from the Medical Research Future Fund, Cancer Research Fellowships Victoria and Department of Health, Disability and Ageing; and is leading the development of the optimal care pathway for people living in rural and remote areas with cancer. Joel Rhee is a Royal Australian College of General Practitioners (RACGP) representative on the Cancer Australia intercollegiate advisory committee, Head of the Discipline of General Practice at UNSW Sydney and Chair of the RACGP Cancer and Palliative Care Specific Interest Group. Cancer Australia was given the opportunity to review this manuscript for factual accuracy. Cancer Australia had no role in the conception, design, analysis, interpretation or writing of the manuscript and had no influence over the content or conclusions. The other authors have no other potential conflicts of interest to disclose.

Acknowledgements

This article is part of a Medical Journal of Australia Collection on the Australian Cancer Plan and is funded by Flinders University. This work did not receive any other specific grant from funding agencies in the public, commercial or not‐for‐profit sectors. We would like to thank Ashleigh Sharman for her assistance across this project.

Artificial Intelligence (AI) statement: All ideas, concepts and arguments are of the authors. The authors used AI (Claude, Anthropic) to assist in formatting the tables and checking the bibliography for duplicate references. All content was reviewed and verified by the authors. AI was not used for any other purpose including drafting of the manuscript or searching the literature. Open access publishing facilitated by Flinders University, as part of the Wiley ‐ Flinders University agreement via the Council of Australasian University Librarians.

Data Availability Statement

This article includes no original data.

References

  • 1. Australian Institute of Health and Welfare (AIHW) , “Australia's Health 2024,” in Brief (AIHW, 2024), accessed January 27, 2026, https://www.aihw.gov.au/getmedia/6b19e493‐0ebe‐420f‐a9a3‐e48b26aace9f/aihw‐aus‐249‐ib.pdf?v=20240715154739&inline=true. [Google Scholar]
  • 2. Haywood D., Chan A., Lustberg M. B., et al., “Planning for Cancer: Building Accessible and High‐Quality Survivorship Care for All,” Trends Cancer 12, no. 4 (2026): 320–327, 10.1016/j.trecan.2025.12.006. [DOI] [PubMed] [Google Scholar]
  • 3. Cancer Australia , “Australian Cancer Plan,” (2023), accessed January 9, 2024, https://www.australiancancerplan.gov.au.
  • 4. Cancer Australia , “Principles of Cancer Survivorship,” (2026), accessed May 25, 2026, https://www.canceraustralia.gov.au/sites/default/files/2026‐02/principles‐of‐cancer‐survivorship.pdf.
  • 5. World Health Organization , “Palliative Care,” (2020), accessed August 10, 2026, https://www.who.int/news‐room/fact‐sheets/detail/palliative‐care.
  • 6. Kruk M. E., Gage A. D., Arsenault C., et al., “High‐Quality Health Systems in the Sustainable Development Goals Era: Time for a Revolution,” Lancet Global Health 6, no. 11 (2018): e1196–e1252, 10.1016/S2214-109X(18)30386-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Blumenthal D., Gumas E. D., Shah A., et al., “Mirror, Mirror 2024. A Portrait of the Failing US Health System: Comparing Performance in 10 Nations,” (2024), accessed January 27, 2026, https://www.commonwealthfund.org/sites/default/files/2024‐10/Blumenthal_mirror_mirror_2024_final_v4.pdf.
  • 8. Duckett S., The Growth and Drivers of Australian Public Hospital Costs and Prices: Analysis and Recommendations (Australian Board of Treasurers, 2025), accessed February, 2026, https://www.treasury.sa.gov.au/__data/assets/pdf_file/0006/1191165/Duckett‐Report‐Growth‐Drivers‐Australian‐Public‐Hospital‐Costs‐Prices.pdf. [Google Scholar]
  • 9. Luo Q., Smith D., David M., et al., “Long‐Term Projections of Cancer Prevalence in Australia to 2050: A Population‐Based Statistical Modelling Study,” Lancet Regional Health—Western Pacific 73 (2026): 101946. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Nash T., Lisy K., Laing E., Kelly H., Cridland K., and Jefford M., “Profiling Current Cancer Survivorship Practices and Enhancing Survivorship Care in Public Hospitals in Victoria, Australia,” Journal of Cancer Survivorship 20 (2024): 1274–1284, 10.1007/s11764-024-01728-7. [DOI] [PubMed] [Google Scholar]
  • 11. Garwood V., Lisy K., and Jefford M., “Survivorship in Colorectal Cancer: A Cohort Study of the Patterns and Documented Content of Follow‐Up Visits,” Journal of Clinical Medicine 9, no. 9 (2020): 2725, 10.3390/jcm9092725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Lisy K., Langdon L., Piper A., and Jefford M., “Identifying the Most Prevalent Unmet Needs of Cancer Survivors in Australia: A Systematic Review,” Asia‐Pacific Journal of Clinical Oncology 15, no. 5 (2019): e68–e78, 10.1111/ajco.13176. [DOI] [PubMed] [Google Scholar]
  • 13. Ee C., Kandagor B., Paterson C., and Vuong K., “The Role of General Practitioners Across the Cancer Continuum Using the Caring Life‐Course Theory,” Seminars in Oncology Nursing 41, no. 6 (2025): 152022, 10.1016/j.soncn.2025.152022. [DOI] [PubMed] [Google Scholar]
  • 14. Lawrence R. A., McLoone J. K., Wakefield C. E., and Cohn R. J., “Primary Care Physicians' Perspectives of Their Role in Cancer Care: A Systematic Review,” Journal of General Internal Medicine 31, no. 10 (2016): 1222–1236, 10.1007/s11606-016-3746-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. NSW Health , “Single Digital Patient Record,” Website Name [Internet]. (2026), accessed March, 2026, https://www.health.nsw.gov.au/single‐digital‐patient‐record/Pages/default.aspx.
  • 16. Phillips R. L., Fisher R., Jackson C., Martin D., Olde Hartman T., and Goodyear‐Smith F., “Sufficient and Efficient Spending on Primary Care Benefits National Health and Health Systems,” Milbank Quarterly 104, no. 2 (2026): 303–323, 10.1111/1468-0009.70075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Courneya K. S., Vardy J. L., O'Callaghan C. J., et al., “Structured Exercise After Adjuvant Chemotherapy for Colon Cancer,” New England Journal of Medicine 393, no. 1 (2025): 13–25, 10.1056/NEJMoa2502760. [DOI] [PubMed] [Google Scholar]
  • 18. Cormie P., Atkinson M., Bucci L., et al., “Clinical Oncology Society of Australia Position Statement on Exercise in Cancer Care,” Medical Journal of Australia 209, no. 4 (2018): 184–187, 10.5694/mja18.00199. [DOI] [PubMed] [Google Scholar]
  • 19. Lynex C., Meehan D., Whittaker K., Buchanan T., and Varlow M., “The Need for Improved Integration of Psychosocial and Supportive Care in Cancer: A Qualitative Study of Australian Patient Perspectives,” Supportive Care in Cancer 33, no. 6 (2025): 516, 10.1007/s00520-025-09593-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Foster M. M., Mitchell G., Haines T., Tweedy S., Cornwell P., and Fleming J., “Does Enhanced Primary Care Enhance Primary Care? Policy‐Induced Dilemmas for Allied Health Professionals,” Medical Journal of Australia 188, no. 1 (2008): 29–32, 10.5694/j.1326-5377.2008.tb01501.x. [DOI] [PubMed] [Google Scholar]
  • 21. Morgan D. D., Currow D. C., Denehy L., and Aranda S. A., “Living Actively in the Face of Impending Death: Constantly Adjusting to Bodily Decline at the End‐of‐Life,” BMJ Supportive & Palliative Care 7, no. 2 (2017): 179–188, 10.1136/bmjspcare-2014-000744. [DOI] [PubMed] [Google Scholar]
  • 22. Brose J. M., Willis E., and Morgan D. D., “The Intentional Pursuit of Everyday Life While Dying: A Longitudinal Qualitative Study of Working‐Aged Adults Living With Advanced Cancer,” Palliative Medicine 37, no. 8 (2023): 1210–1221, 10.1177/02692163231180911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Palliative Care Outcomes Collaboration , “PCOC National Outcome Measures and Benchmarks,” (2014), accessed March, 2026, https://documents.uow.edu.au/content/groups/public/@web/@chsd/@pcoc/documents/doc/uow264946.pdf.
  • 24. Australian Institute of Health and Welfare , Palliative Care Workforce (AIHW, 2025), accessed March 25, 2026, https://www.aihw.gov.au/reports/palliative‐care‐services/palliative‐care‐services‐in‐australia/contents/palliative‐care‐workforce. [Google Scholar]
  • 25. Yap S., Luo Q., Cuff J., et al., “Disparities in Cancer Survival by Socioeconomic Status: Findings From a Population‐Based Study of 942 241 Australians From 1980 to 2019,” Journal of the National Cancer Institute 118, no. 7 (2025): 1313–1319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Australian Institute of Health and Welfare (AIHW) , “Cancer Screening,” Website Name [Internet] (2024), accessed July, 2024, https://www.aihw.gov.au/reports/australias‐health/cancer‐screening‐and‐treatment.
  • 27. Afshar N., English D. R., and Milne R. L., “Factors Explaining Socio‐Economic Inequalities in Cancer Survival: A Systematic Review,” Cancer Control 28 (2021): 10732748211011956, 10.1177/10732748211011956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Ugalde A., Jongebloed H., Wright C., et al., “Towards Equitable Cancer Outcomes for Rural and Remote Communities: Reflections, Lessons and Recommendations,” Lancet Regional Health—Western Pacific 66 (2025): 101756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Scanlon B., Brough M., Wyld D., and Durham J., “Equity Across the Cancer Care Continuum for Culturally and Linguistically Diverse Migrants Living in Australia: A Scoping Review,” Globalization and Health 17, no. 1 (2021): 87, 10.1186/s12992-021-00737-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Kwok C. and White K., “Cultural and Linguistic Isolation: The Breast Cancer Experience of Chinese‐Australian Women—A Qualitative Study,” Contemporary Nurse 39, no. 1 (2011): 85–94, 10.5172/conu.2011.39.1.85. [DOI] [PubMed] [Google Scholar]
  • 31. Boonman A. J., Cuypers M., Leusink G. L., Naaldenberg J., and Bloemendal H. J., “Cancer Treatment and Decision Making in Individuals With Intellectual Disabilities: A Scoping Literature Review,” Lancet Oncology 23, no. 4 (2022): e174–e183, 10.1016/S1470-2045(21)00694-X. [DOI] [PubMed] [Google Scholar]
  • 32. Australian Institute of Health and Welfare , Rural and Remote Health (AIHW, 2025), accessed April 5, 2026, https://www.aihw.gov.au/reports/rural‐remote‐australians/rural‐and‐remote‐health. [Google Scholar]
  • 33. Underhill C., Sabesan S., and Zielinski R., “Best of Both Worlds? Linking Comprehensive and Noncomprehensive Cancer Centers,” Cancers (Basel) 131, no. 12 (2025): e35907, 10.1002/cncr.35907. [DOI] [PubMed] [Google Scholar]
  • 34. Thamm C., Button E., Johal J., et al., “Describing the Core Attributes and Impact of Comprehensive Cancer Centers Internationally: A Chronological Scoping Review,” Cancers (Basel) 17, no. 6 (2025): 1023, 10.3390/cancers17061023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Cancer Australia , “Australian Comprehensive Cancer Network Framework,” (2024), accessed February 2026, https://www.canceraustralia.gov.au/sites/default/files/2024‐10/australian‐comprehensive‐cancer‐network‐framework.pdf.
  • 36. Chan R. J., Crawford‐Williams F., Crichton M., et al., “Effectiveness and Implementation of Models of Cancer Survivorship Care: An Overview of Systematic Reviews,” Journal of Cancer Survivorship 17, no. 1 (2023): 197–221, 10.1007/s11764-021-01128-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Chan R., McErlean G., Crawford‐Williams F., et al., “The Contribution of Nurses to Cancer Survivorship Care in Australia,” (2026), accessed April 7, 2026, https://www.cnsa.org.au/resource/world‐cancer‐day‐new‐joint‐cnsa‐cosa‐cancer‐survivorship‐position‐statement.html. [DOI] [PubMed]
  • 38. Paterson C., Chau M., Turner M. R., and Primeau C., “What Is the Lived Experience of People Affected by Cancer, Family Members, and Their Treatment Team Engaged in Patient Initiated Follow‐Up and Preferences in Cancer Care: A Qualitative Systematic Review,” Seminars in Oncology Nursing 41, no. 6 (2025): 152041, 10.1016/j.soncn.2025.152041. [DOI] [PubMed] [Google Scholar]
  • 39. Emery J. D., Jefford M., King M., et al., “ProCare Trial: A Phase II Randomized Controlled Trial of Shared Care for Follow‐Up of Men With Prostate Cancer,” BJU International 119, no. 3 (2017): 381–389, 10.1111/bju.13593. [DOI] [PubMed] [Google Scholar]
  • 40. Jefford M., Emery J. D., James Martin A., et al., “SCORE: A Randomised Controlled Trial Evaluating Shared Care (General Practitioner and Oncologist) Follow‐Up Compared to Usual Oncologist Follow‐Up for Survivors of Colorectal Cancer,” EClinicalMedicine 66 (2023): 102346, 10.1016/j.eclinm.2023.102346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Chan R. J., Crawford‐Williams F., Han C. Y., et al., “Implementing a Nurse‐Enabled, Integrated, Shared‐Care Model Involving Specialists and General Practitioners in Early Breast Cancer Post‐Treatment Follow‐Up (EMINENT): A Single‐Centre, Open‐Label, Phase 2, Parallel‐Group, Pilot, Randomised, Controlled Trial,” EClinicalMedicine 81 (2025): 103090, 10.1016/j.eclinm.2025.103090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Lisy K., Kent J., Piper A., and Jefford M., “Facilitators and Barriers to Shared Primary and Specialist Cancer Care: A Systematic Review,” Supportive Care in Cancer 29, no. 1 (2021): 85–96, 10.1007/s00520-020-05624-5. [DOI] [PubMed] [Google Scholar]
  • 43. Garcia‐Vivar C., Elizondo N., and Ambrosio L., “Primary Care Nursing Is Essential to Fully Implement Survivorship Care Plans for Long‐Term Cancer Survivors and Their Families,” Cancer Nursing 42, no. 3 (2019): 177–178, 10.1097/NCC.0000000000000704. [DOI] [PubMed] [Google Scholar]
  • 44. Dobson C., Deane J., Macdonald S., et al., “Barriers to Early Presentation Amongst Rural Residents Experiencing Symptoms of Colorectal Cancer: A Qualitative Interview Study,” Cancers (Basel) 15, no. 1 (2023): 274, 10.3390/cancers15010274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Chandrakumar A., Hoon E., Benson J., and Stocks N., “Barriers and Facilitators to Cervical Cancer Screening for Women From Culturally and Linguistically Diverse Backgrounds; a Qualitative Study of GPs,” BMJ Open 12, no. 11 (2022): e062823, 10.1136/bmjopen-2022-062823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Ward E., Jemal A., Cokkinides V., et al., “Cancer Disparities by Race/Ethnicity and Socioeconomic Status,” CA: A Cancer Journal for Clinicians 54, no. 2 (2004): 78–93, 10.3322/canjclin.54.2.78. [DOI] [PubMed] [Google Scholar]
  • 47. Australian Government Department of Health , Exploratory Analysis of Barriers to Palliative Care: Issues Report on People From Culturally and Linguistically Diverse Backgrounds (Australian Government Department of Health, 2019), accessed February 3, 2026, https://www.health.gov.au/resources/publications/exploratory‐analysis‐of‐barriers‐to‐palliative‐care‐issues‐report‐on‐people‐from‐culturally‐and‐linguistically‐diverse‐backgrounds?language=en. [Google Scholar]
  • 48. Norman K., Gunatillaka N., West K., and Sturgiss E., “What Happens in General Practitioner Consultations? A Study of Video‐Recorded Australian General Practitioner Consultations,” Australian Journal of General Practice 54 (2025): 737–742, 10.31128/AJGP-02-25-7561. [DOI] [PubMed] [Google Scholar]
  • 49. Bourke L., Humphreys J. S., Wakerman J., and Taylor J., “Understanding Rural and Remote Health: A Framework for Analysis in Australia,” Health & Place 18, no. 3 (2012): 496–503, 10.1016/j.healthplace.2012.02.009. [DOI] [PubMed] [Google Scholar]
  • 50. Kiss N., Isenring E., Gough K., et al., “Early and Intensive Dietary Counseling in Lung Cancer Patients Receiving (Chemo)radiotherapy—A Pilot Randomized Controlled Trial,” Nutrition and Cancer 68, no. 6 (2016): 958–967, 10.1080/01635581.2016.1188972. [DOI] [PubMed] [Google Scholar]
  • 51. Erickson N., Sulosaari V., Sullivan E. S., et al., “Nutrition Care in Cancer: An Overlooked Part of Patient‐Centered Care,” Seminars in Oncology Nursing 41, no. 1 (2025): 151799, 10.1016/j.soncn.2024.151799. [DOI] [PubMed] [Google Scholar]
  • 52. Courneya K. S., Lucia A., May A. M., Rundqvist H., and Rogers L. Q., “Multidisciplinary Perspectives in Exercise Oncology Across the Translational Research Continuum,” Journal of the National Cancer Institute. Monographs 2025, no. 71 (2025): 315–324, 10.1093/jncimonographs/lgaf032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Cormie P., Bradford A., Doran C. M., et al., “Willingness to Pay for Exercise Oncology Services: A Mixed Methods Study,” Supportive Care in Cancer 33, no. 2 (2025): 77, 10.1007/s00520-024-09105-x. [DOI] [PubMed] [Google Scholar]
  • 54. Pearce C., Phillips R., Richardson A., Volker N., and Mitterfellner R., “Implementation of the Allied Health Assistant Workforce in the Australian Context: An Integrative Review,” Journal of Multidisciplinary Healthcare 18 (2025): 7979–8004, 10.2147/JMDH.S561660. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Barbieri M., Richardson G., and Paisley S., “The Cost‐Effectiveness of Follow‐Up Strategies After Cancer Treatment: A Systematic Literature Review,” British Medical Bulletin 126, no. 1 (2018): 85–100, 10.1093/bmb/ldy011. [DOI] [PubMed] [Google Scholar]
  • 56. Hussain M., Chau S., Turner M., and Paterson C., “Scan‐Associated Distress in People Affected by Cancer: A Qualitative Systematic Review,” Seminars in Oncology Nursing 39, no. 5 (2023): 151502, 10.1016/j.soncn.2023.151502. [DOI] [PubMed] [Google Scholar]
  • 57. Galjart B., Höppener D. J., Aerts J. G. J. V., Bangma C. H., Verhoef C., and Grünhagen D. J., “Follow‐Up Strategy and Survival for Five Common Cancers: A Meta‐Analysis,” European Journal of Cancer 174 (2022): 185–199, 10.1016/j.ejca.2022.07.025. [DOI] [PubMed] [Google Scholar]
  • 58. World Health Organisation , Policy Brief on Integrating Rehabilitation Into Palliative Care Services (WHO Regional Office for Europe, 2023), accessed March 25, 2026, https://iris.who.int/server/api/core/bitstreams/a432f684‐8a8a‐4d16‐a6dc‐eeb099b423b9/content. [Google Scholar]
  • 59. Farrer O. and Tieman J., “What Evidence Exists to Support Palliative Allied Health Practice in Aged Care: A Scoping Review,” Healthcare (Basel) 12, no. 19 (2024): 1973, 10.3390/healthcare12191973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Allied Health Professions Australia , “Value of Allied Health in Residential Aged Care,” (2021), accessed February 3, 2025, https://documents.parliament.qld.gov.au/com/HEC‐B5E1/INDISQ‐3CD2/220224%20‐%20Allied%20Health%20Professionals%20‐%2021%20February%202022.pdf.
  • 61. Pryde K., Lakhani A., William L., and Dennett A., “Palliative Rehabilitation and Quality of Life: Systematic Review and Meta‐Analysis,” BMJ Supportive & Palliative Care 16, no. 5 (2024): 1043–1053, 10.1136/spcare-2024-004972. [DOI] [PubMed] [Google Scholar]
  • 62. Manning B., Kelly R., and Broome K., “Assistive Technology in Palliative Care: A Statewide Equipment Programme,” BMJ Supportive & Palliative Care 14 (2024): e500–e503, 10.1136/spcare-2022-004048. [DOI] [PubMed] [Google Scholar]
  • 63. Segelov E., Carrington C., Aranda S., et al., “Developing Clinical Indicators for Oncology: The Inaugural Cancer Care Indicator Set for the Australian Council on Healthcare Standards,” Medical Journal of Australia 214, no. 11 (2021): 528–531, 10.5694/mja2.51087. [DOI] [PubMed] [Google Scholar]
  • 64. Lisy K., Ly L., Kelly H., Clode M., and Jefford M., “How Do We Define and Measure Optimal Care for Cancer Survivors? An Online Modified Reactive Delphi Study,” Cancers 13, no. 10 (2021): 2299, 10.3390/cancers13102299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65. Howell D., Molloy S., Wilkinson K., et al., “Patient‐Reported Outcomes in Routine Cancer Clinical Practice: A Scoping Review of Use, Impact on Health Outcomes, and Implementation Factors,” Annals of Oncology 26, no. 9 (2015): 1846–1858, 10.1093/annonc/mdv181. [DOI] [PubMed] [Google Scholar]
  • 66. University of Wollongong , “Palliative Care Outcomes Collaboration,” Website Name [Internet] (2026), accessed April 2026, https://www.uow.edu.au/australasian‐health‐outcomes‐consortium/pcoc/.
  • 67. National Cancer Patient Experience Survey , “Tell Us About Your Experience of Cancer Care,” Website Name [Internet] (2026), accessed March 2026, https://www.ncpes.co.uk/.
  • 68. National Disease Registration Service , “Cancer Quality of Life,” Website Name [Internet] (2025), accessed March 2026, https://digital.nhs.uk/ndrs/data/data‐outputs/cancer‐data‐hub/cancer‐quality‐of‐life‐survey.
  • 69. Fuentes‐García A., Flores‐Figueroa C., and Castillo‐Delgado A., “Sociodemographic, Political, and Policy Contexts of Cancer Care: A Comparative Analysis of Countries With the Highest Survival Rates,” Journal of Cancer Policy 43 (2025): 100559, 10.1016/j.jcpo.2025.100559. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

This article includes no original data.


Articles from The Medical Journal of Australia are provided here courtesy of Wiley

RESOURCES